Martina E Spehlmann

Summary

Affiliation: Campus Kiel
Country: Germany

Publications

  1. ncbi Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study
    Martina E Spehlmann
    Institute for Clinical Molecular Biology, University Schleswig Holstein, Kiel, Germany
    Inflamm Bowel Dis 14:968-76. 2008
  2. ncbi Risk factors in German twins with inflammatory bowel disease: results of a questionnaire-based survey
    Martina E Spehlmann
    Clinic of General Internal Medicine, University Hospital Schleswig Holstein, Campus Kiel, Schittenhelmstrasse 12, 24105 Kiel, Germany
    J Crohns Colitis 6:29-42. 2012
  3. ncbi Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis
    Patricia Lepage
    Institute of Clinical Molecular Biology, Christian Albrechts University Kiel, Kiel, Germany
    Gastroenterology 141:227-36. 2011
  4. ncbi Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial
    Stephan R Targan
    Inflammatory Bowel Disease Center and Division of Gastroenterology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Gastroenterology 132:1672-83. 2007

Collaborators

Detail Information

Publications4

  1. ncbi Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study
    Martina E Spehlmann
    Institute for Clinical Molecular Biology, University Schleswig Holstein, Kiel, Germany
    Inflamm Bowel Dis 14:968-76. 2008
    ..The aim of our study was to determine the concordance rates for IBD in German twin pairs and to evaluate clinical characteristics of concordant and discordant twin pairs...
  2. ncbi Risk factors in German twins with inflammatory bowel disease: results of a questionnaire-based survey
    Martina E Spehlmann
    Clinic of General Internal Medicine, University Hospital Schleswig Holstein, Campus Kiel, Schittenhelmstrasse 12, 24105 Kiel, Germany
    J Crohns Colitis 6:29-42. 2012
    ..Environmental factors may play an important role in the pathogenesis of IBD. The history of patients of the German IBD twin study was analyzed by questionnaires and interviews...
  3. ncbi Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis
    Patricia Lepage
    Institute of Clinical Molecular Biology, Christian Albrechts University Kiel, Kiel, Germany
    Gastroenterology 141:227-36. 2011
    ..We analyzed the interaction between gastrointestinal mucosal microbiota and host genes in twin pairs discordant for ulcerative colitis (UC) to study the functional interaction between microbiota and mucosal epithelium...
  4. ncbi Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial
    Stephan R Targan
    Inflammatory Bowel Disease Center and Division of Gastroenterology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Gastroenterology 132:1672-83. 2007
    ..A randomized placebo-controlled trial evaluated the efficacy of natalizumab induction therapy in patients with Crohn's disease...